Phumla Z. Sinxadi
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Lenacapavir as pre-exposure prophylaxis for HIV prevention.
Journal: The Cochrane database of systematic reviews
Published: April 01, 2026
Genetic polymorphisms and adverse reactions to antituberculosis therapy.
Journal: Pharmacogenomics
Published: June 20, 2025
The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 18, 2025
NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans.
Journal: Frontiers in genetics
Published: April 08, 2025
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid.
Journal: Southern African journal of HIV medicine
Published: October 03, 2024
Where does doravirine fit in current antiretroviral therapy?
Journal: The lancet. HIV
Published: July 24, 2024
Advancing pharmacometrics in Africa-Transition from capacity development toward job creation.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 29, 2024
Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans.
Journal: Journal of personalized medicine
Published: May 22, 2024
The long wait for long-acting HIV prevention and treatment formulations.
Journal: The lancet. HIV
Published: March 23, 2024
Obesity is South Africa's new HIV epidemic.
Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Published: February 13, 2024
Last Updated: 09/26/2026